Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 12, Issue 4 (2023)

Hemovigilance: A step to safe blood transfusion

Author(s):
Arpita Shrivastav, Neeraj Shrivastava, Nitesh Kumar, Swatantra Kumar Singh, Rajeev Ranjan, Amit Kumar Jha and Durgesh Kumar Mishra
Abstract:
Hemovigilance is projected for the recognition and studying all inconvenient possessions of blood transfusion to accurate their basis and foil reappearance. Transfusion services trust on transfusion response reportage to offer patient care and shield the blood stock. Redundant withdrawal of blood is a major depletion of unusual blood, as well as man, hours, and reserves. Although strict measures are pragmatic during blood contributions arrangements and transfusions, errors in transfusion and infection snags serve a problem in clinical practice. The monitoring, investigation and analysis of hostile measures creates applicable data for the eminence set of these systems, pouring continuous upgrading in blood transfusion practice. Endorsements based on findings have led to variations in clinical strategies and plans. Despite the advancement further developments are still needed. Current challenges are low resource settings, the international coordination of descriptions and the preclusion of underreporting. In count, the connecting affiliation between the transfusion and the reaction is often uncertain. Biomarkers may help in the imputability assessment and their role in the analysis of blood transfusion reactions needs to be more explored.
Pages: 1824-1827  |  161 Views  100 Downloads


The Pharma Innovation Journal
How to cite this article:
Arpita Shrivastav, Neeraj Shrivastava, Nitesh Kumar, Swatantra Kumar Singh, Rajeev Ranjan, Amit Kumar Jha, Durgesh Kumar Mishra. Hemovigilance: A step to safe blood transfusion. Pharma Innovation 2023;12(4):1824-1827.

Call for book chapter